Roberts, Glore & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.49M | Buy |
|
|||||
|
2025
Q2 | $1.42M | Buy |
|
|||||
|
2025
Q1 | $770K | Buy |
|
|||||
|
2024
Q4 | $270K | Sell |
|
|||||
|
2024
Q3 | $382K | Sell |
|
|||||
|
2024
Q2 | $490K | Hold |
|
|||||
|
2024
Q1 | $440K | Sell |
|
|||||
|
2023
Q4 | $365K | Sell |
|
|||||
|
2023
Q3 | $334K | Sell |
|
|||||
|
2023
Q2 | $307K | Buy |
|
|||||
|
2023
Q1 | $298K | Sell |
|
|||||
|
2022
Q4 | $257K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $223K | Hold |
|
|||||
|
2022
Q1 | $222K | Sell |
|
|||||
|
2021
Q4 | $314K | Hold |
|
|||||
|
2021
Q3 | $269K | Hold |
|
|||||
|
2021
Q2 | $235K | Buy |
|